Search

Your search keyword '"Cunningham, Evan B."' showing total 13 results
Start Over Author "Cunningham, Evan B." Journal international journal of drug policy
13 results on '"Cunningham, Evan B."'

1. Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: A systematic review and meta-analysis

Author

Cunningham, Evan B., Wheeler, Alice, Hajarizadeh, Behzad, French, Clare E., Roche, Rachel, Marshall, Alison D., Fontaine, Guillaume, Conway, Anna, Bajis, Sahar, Valencia, Braulio M., Presseau, Justin, Ward, John W., Degenhardt, Louisa, Dore, Gregory J., Hickman, Matthew, Vickerman, Peter, and Grebely, Jason

Published
2023
Full Text
View/download PDF

5. Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy

Author

Grebely, Jason, Conway, Brian, Cunningham, Evan B., Fraser, Chris, Moriggia, Alberto, Gane, Ed, Stedman, Catherine, Cooper, Curtis, Castro, Erika, Schmid, Patrick, Petoumenos, Kathy, Hajarizadeh, Behzad, Marks, Phillipa, Erratt, Amanda, Dalgard, Olav, Lacombe, Karine, Feld, Jordan J., Bruneau, Julie, Daulouede, Jean-Pierre, Powis, Jeff, Bruggmann, Philip, Matthews, Gail V., Kronborg, Ian, Shaw, David, Dunlop, Adrian, Hellard, Margaret, Applegate, Tanya L., Crawford, Sione, and Dore, Gregory J

Published
2018
Full Text
View/download PDF

6. Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The SIMPLIFY study

Author

Cunningham, Evan B., Amin, Janaki, Feld, Jordan J., Bruneau, Julie, Dalgard, Olav, Powis, Jeff, Hellard, Margaret, Cooper, Curtis, Read, Phillip, Conway, Brian, Dunlop, Adrian J., Norton, Briana, Litwin, Alain H., Hajarizadeh, Behzad, Thurnheer, Maria Christine, Dillon, John F., Weltman, Martin, Shaw, David, Bruggmann, Philip, Gane, Edward, Fraser, Chris, Marks, Philippa, Applegate, Tanya L., Quiene, Sophie, Siriragavan, Sharmila, Matthews, Gail V., Dore, Gregory J., and Grebely, Jason

Published
2018
Full Text
View/download PDF

7. Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in Australia

Author

Bajis, Sahar, Maher, Lisa, Treloar, Carla, Hajarizadeh, Behzad, Lamoury, Francois M.J., Mowat, Yasmin, Schulz, Marcel, Marshall, Alison D., Cunningham, Evan B., Cock, Victoria, Ezard, Nadine, Gorton, Carla, Hayllar, Jeremy, Smith, Julie, Whelan, Michelle, Martinello, Marianne, Applegate, Tanya L., Dore, Gregory J., and Grebely, Jason

Published
2018
Full Text
View/download PDF

10. Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs: The ACTIVATE study

Author

Midgard, Håvard, Hajarizadeh, Behzad, Cunningham, Evan B., Conway, Brian, Backmund, Markus, Bruggmann, Philip, Bruneau, Julie, Bourgeois, Stefan, Dunlop, Adrian, Foster, Graham R., Hellard, Margaret, Robaeys, Geert, Thurnheer, Maria C., Weltman, Martin, Amin, Janaki, Marks, Philippa S., Quiene, Sophie, Dore, Gregory J., Dalgard, Olav, and Grebely, Jason

Published
2017
Full Text
View/download PDF

11. Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE study

Author

Grebely, Jason, Dalgard, Olav, Cunningham, Evan B., Hajarizadeh, Behzad, Foster, Graham R., Bruggmann, Philip, Conway, Brian, Backmund, Markus, Robaeys, Geert, Swan, Tracy, Amin, Janaki, Marks, Philippa S., Quiene, Sophie, Applegate, Tanya L., Weltman, Martin, Shaw, David, Dunlop, Adrian, Hellard, Margaret, Bruneau, Julie, Midgard, Håvard, Bourgeois, Stefan, Staehelin, Cornelia, and Dore, Gregory J.

Published
2017
Full Text
View/download PDF

12. Progress and remaining challenges to address hepatitis C, other infectious diseases, and drug-related harms to improve the health of people who use drugs

Author

Grebely, Jason, primary, Collins, Alexandra B., additional, Artenie, Andreea Adelina, additional, Sutherland, Rachel, additional, Meyer, Jaimie P., additional, Barocas, Joshua A., additional, Falade-Nwulia, Oluwaseun, additional, Cepeda, Javier A., additional, Cunningham, Evan B., additional, Hajarizadeh, Behzad, additional, Lafferty, Lise, additional, Lazarus, Jeffrey V., additional, Bonn, Matthew, additional, Marshall, Alison D., additional, and Treloar, Carla, additional

Published
2021
Full Text
View/download PDF

13. Longitudinal injecting risk behaviours among people with a history of injecting drug use in an Australian prison setting: The HITS-p study

Author

Fabio Luciani, Behzad Hajarizadeh, Andrew R. Lloyd, Evan B Cunningham, Neil Arvin Bretaña, Sarah Larney, Jason Grebely, Gregory J. Dore, Janaki Amin, Louisa Degenhardt, Cunningham, Evan B, Hajarizadeh, Behzad, Amin, Janaki, Bretana, Neil, Dore, Gregory J, Degenhardt, Louisa, Larney, Sarah, Luciani, Fabio, Lloyd, Andrew R, and Grebely, Jason

Subjects
Adult, Male, medicine.medical_specialty, incarceration, media_common.quotation_subject, Psychological intervention, 030508 substance abuse, Medicine (miscellaneous), Prison, Young Adult, 03 medical and health sciences, Risk-Taking, 0302 clinical medicine, injection drug use, prevention, Humans, Medicine, Needle Sharing, 030212 general & internal medicine, Substance Abuse, Intravenous, Syringe, media_common, Needle sharing, young, business.industry, Prisoners, Health Policy, opioid substitution therapy, NSP, Age Factors, Australia, virus diseases, Odds ratio, medicine.disease, Treatment as prevention, Substance abuse, Family medicine, Female, 0305 other medical science, business, Cohort study
Abstract

usc Background: HCV transmission remains high in prisons globally. Understanding injecting risk behaviours in prisons is crucial to effectively develop and implement HCV prevention programs in this setting including treatment as prevention. Methods: HITS-p is a cohort study which enrolled people with a history of injecting drug use in prisons in NSW, Australia from 2005 to 2013. Participants completed an interview at enrolment and follow-up visits to determine injecting behaviours. Generalized estimating equation (GEE) and logistic regression methods were used to assess injecting risk behaviours prior to and following prison entry and to investigate injecting risk behaviours in prison. Results: Overall, 499 participants with a history of injecting drug use were included (median age, 26 years; 65% male). Participants were significantly less likely to inject drugs following incarceration. Among injectors, participants were less likely to inject ≥weekly but more likely to share a needle/syringe. At enrolment, the proportion reporting any injecting, ≥weekly injecting, and needle/syringe sharing in prison was highest among younger individuals. Younger age was associated with both re-initiation and continuation of injecting drug use following prison entry. Among those continuously imprisoned, younger age was associated with increased odds of any injecting, ≥weekly injecting, and sharing a needle/syringe. Conclusions: Upon entry to prison, injecting drug use decreased but syringe sharing increased among injectors. Younger individuals are most likely to exhibit high-risk injecting behaviours in prison. These data highlight the need for improved HCV prevention strategies (including improved needle/syringe access and scale up of HCV therapy) for those at increased risk of HCV transmission in prison, including younger individuals. Refereed/Peer-reviewed

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results